Covaxin
Vaccineexperimental
Clinical trial activity
5 trials · 19 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started Jul 13, 2020 (NCT04471519)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05522335 | Phase 3 | Apr 16, 2022 | Bharat Biotech International Limited |
| NCT05567471 | Phase 3 | Feb 26, 2022 | All India Institute of Medical Sciences, Bharat Biotech International Limited, ESIC Medical College and Hospital Faridabad, Jeevan Rekha Hospital, Belguam |
| NCT05639998 | Phase 2 | Sep 1, 2021 | Bharat Biotech International Limited |
| NCT04918797 | Phase 2/Phase 3 (Phase 3) | May 26, 2021 | All India Institute of Medical Sciences, Bharat Biotech International Limited, Cheluvambha Hospital,Mysore, JLN Medical college,Ajmer, Meditrina Institute of Medical Sciences,Nagpur, Prakhar Hospital, Kanpur, Pranam Hospitals Hyderabad, Victoria Government Hospital |
| NCT04471519 | Phase 1/Phase 2 (Phase 2) | Jul 13, 2020 | All India Institute of Medical Sciences, Bharat Biotech International Limited, Gillukar Multispeciality Hospital, Nagpur, IMS & SUM Hospital, Orissa, Indian Council of Medical Research, Jeevan Rekha Hospital, Belguam, King George Hospital Visakhapatnam, Nizam's Institute of Medical Sciences, Hyderabad, India, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Prakhar Hospital, Kanpur, Rana Hospital and Trauma Centre, Gorakhpur, Redkar Hospital and Research Centre Goa, SRM Hospital and Research Centre, Chennai |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (19)
19 organizations
Page 1 / 1